CAREDX, INC. CHANGE OF CONTROL AND SEVERANCE AGREEMENTChange of Control and Severance Agreement • November 4th, 2024 • CareDx, Inc. • Services-medical laboratories • California
This Change of Control and Severance Agreement (the “Agreement”) is made and entered into by and between Jessica Meng (“Executive”) and CareDx, Inc., a Delaware corporation (the “Company”), effective as of August 30, 2024 (the “Effective Date”).
SEPARATION AGREEMENT AND RELEASE OF CLAIMSSeparation Agreement • November 4th, 2024 • CareDx, Inc. • Services-medical laboratories • California
This Separation Agreement and Release of Claims (this “Agreement”) is made by and between CareDx, Inc. (the “Company”), and Alexander Johnson (“Executive”). The Company and Executive are sometimes collectively referred to herein as the “Parties” and individually referred to as a “Party.”
CONFIDENTIAL INFORMATION, INVENTION ASSIGNMENT, NON-COMPETITION,Confidential Information, Invention Assignment, Non-Competition, and Arbitration Agreement • November 4th, 2024 • CareDx, Inc. • Services-medical laboratories
As a condition of my employment with CareDx, its subsidiaries, affiliates, successors, or assigns (together the “Company”), my receipt of confidential information, and the compensation now and hereafter paid to me and benefits provided to me by the Company, I agree to the following provisions of this CareDx Confidential Information, Invention Assignment, Non-Competition and Arbitration Agreement (the “Agreement”):
CONSULTING AGREEMENTConsulting Agreement • November 4th, 2024 • CareDx, Inc. • Services-medical laboratories • California
This Consulting Agreement (“Agreement”) is entered into on September 30, 2024 and is effective on September 14, 2024 (“Effective Date”) and is between CareDx, Inc., with a business address at 8000 Marina Blvd, Brisbane, CA 94005 (“CareDx” or the “Company”) and Alexander Johnson (“Consultant”). CareDx and Consultant may be referred to individually as a (“Party”) and collectively as the (“Parties”).
